Patient: Page 14
-
PharmaVoice Team/PharmaVoice
20 Years in the Making: Special Section
From day one our goal has been to convene a community of experts who would be committed to our mission of: read, think, and participate. And you have. PharmaVOICE is proud to celebrate the contributions of thousands of thought leaders and subject matter experts who have lent their insights on a w...
By PharmaVoice Team • March 1, 2021 -
PharmaVoice Team/PharmaVoice
Commanders & Chiefs: Chief Patient Officers
More and more companies are elevating patient-facing roles to the C-Suite, as a result, these key roles continue to expand and evolve to address the goals of patient-centricity and patient engagement. Dr. Julie Gerberding Merck Respecting Voices Across the Spectrum of Advocacy The concept of pati...
By PharmaVoice Team • March 1, 2021 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Fulfilling a Great Promise
Analysts attribute the continued growth of the cell and gene therapy (CGT) market to steady investment and consolidation in cell and gene therapies, with 16 out of the 20 largest biopharma companies adding CGT products to their portfolios. In the recent past, cell and gene therapies have emerged ...
By PharmaVoice Team • Feb. 1, 2021 -
PharmaVoice Team/PharmaVoice
Innovator's Journey
Every entrepreneur’s path is unique, yet they share some core characteristics. They are willing to take calculated risks, they are visionary, they are fearless, and they are always thinking about the next big thing. The statistics are somewhat sobering: 20% of new companies fail in thei...
By PharmaVoice Team • Jan. 1, 2021 -
PharmaVoice Team/PharmaVoice
How AI Can Improve Understanding of Patient's Behavior and Symptoms
Running and managing clinical trials, at the most basic level, is about creating a foundation to get the best possible data. While a great deal of thought goes into recruiting the right patients and developing the most effective protocols, initiatives designed to improve the experience for the pa...
By Michelle Marlborough • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Patient Solutions: The Changing Face of Patient Engagement
Digital technologies are changing the healthcare landscape, creating opportunities for patient-support programs, patient monitoring and self-management. There is massive demand for patient-engagement solutions, with predictions that the market for such solutions will reach $30.36 billion by 2026....
By PharmaVoice Team • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Advancing Beyond the Traditional Patient Adherence Model
Delivering value in the era of empowered patients renders the one-size-fits-all patient services program obsolete. Not every treatment journey is consistently linear within a disease state because patients take different paths to medication adherence. For example, one patient may be compliant whe...
By Maria Kirsch • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Social Connection Is Possible in a Time of Physical Distancing
In this time of physical distancing, technology often seems like the go-to solution for helping people connect. However, data linking social media and depression, as well as research pointing to social divisiveness online, might give us pause. Recent survey results found most Americans believe th...
By Amrita Bhowmick • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Listening to the Patient for Better Outcomes
The aim of drug development is to improve patient outcomes. Historically, clinical research has been driven by researchers, with little or no input from patients, contributing to many of the challenges and inefficiencies we see in today’s clinical trials. Some of these challenges include low enro...
By Gretchen Goller • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Speak Out: The Power of Virtual Patient Simulation in CME
Simulation as we think of it today has been used in medical education since the 18th century,1 and has continued to evolve into realistic and medically accurate physical and digital solutions designed to allow learners to simulate a scenario-based encounter with a patient in a safe environment. V...
By Martin Warters • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Accessible Healthcare: The Key Role of Health Literacy
Health literacy can have a significant bearing on outcomes, so helping patients understand their health and treatments is critical. Health information is by its very nature complex. Explaining a disease or how to take a drug or a drug’s potential side effects to a patient can be difficult and can...
By Kim Ribbink • Sept. 1, 2020 -
PharmaVoice Team/PharmaVoice
Mentors
These champions of diversity and inclusion are dedicated to developing the next generation of leaders and setting an example for others to follow. An Ally for All Raising the bar… by bringing people together Peter Anastasiou Title: Executive VP & Head of North America Company: Lundbeck Indust...
By PharmaVoice Team • Aug. 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient Access: Keeping the Channel Open During a Crisis
A managed access program enables pharmaceutical and biotechnology companies to make certain investigational or unapproved treatments available to eligible patients through their prescribing physicians. But what happens when the supply chain is disrupted by a pandemic, such as COVID-19? The worldw...
By Carolyn Gretton • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Commanders & Chiefs
The role of chief technology officer has become more encompassing as companies adopt new software and technology-based solutions to solve some of their biggest challenges and create opportunities for new rewards. Zaher El-Assi Decentralizing & Accelerating Trials Next-generation innovations t...
By PharmaVoice Team • May 1, 2020 -
PharmaVoice Team/PharmaVoice
Upfront
BMS Undergoes Brand Transformation Bristol Myers Squibb has revealed a new brand to reflect its evolution in light of its acquisition of Celgene for $74 billion late last year. The changes reflect an updated website, logo, and a change in punctuation — removing the hyphen between Bristol and Myer...
By PharmaVoice Team • April 1, 2020 -
PharmaVoice Team/PharmaVoice
HealthTech
Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox Trend Watch: HealthTech Innovations Continue to Transform Patient Care Boehringer Ingelheim and Carebox Healthcare Solutions have launched MyStudyWindow, a digital platform empowering patients, families, caregivers, an...
By PharmaVoice Team • April 1, 2020 -
PharmaVoice Team/PharmaVoice
HBA's Rising Stars and Luminaries
The HBA’s 2020 Rising Stars and Luminaries provide their insights on the trends they are tracking that they believe will impact the industry in the future. In 2020, the Healthcare Businesswomen’s Association is honoring more than 140 extraordinary women representing all facets of the life-science...
By PharmaVoice Team • April 1, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The patient experience We are excited to publish the third annual Patient Voice issue. This special publication is dedicated to raising the voice of patients and sharing their insights on topics ranging from drug discovery and development through commercialization. We also have tapped nearly 100 ...
By Taren Grom • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Upfront
Teva and Direct Relief Partner to Bring Cancer Medicines to Africa Global HOPE (Hematology-Oncology Pediatric Excellence), a program of Texas Children’s Hospital, Teva Pharmaceutical Industries, and Direct Relief are partnering to provide access to medications in sub-Saharan Africa, where a major...
By PharmaVoice Team • March 1, 2020 -
PharmaVoice Team/PharmaVoice
The Power of Patients
Patient engagement is permeating all spheres of the healthcare ecosystem. On the cover… This month’s cover image is a self-portrait painted by Casey Ford, age 19, who has a rare connective tissue disorder, which is characterized by under-developed, absent, or misplaced/misaligned kneecaps in newb...
By Taren Grom • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient Gallery
Last year, we were honored to feature the art work of Max Schill, now 11, who remains an active patient advocate, and who helped pass the 21st Century Cure Act. We are excited to continue this tradition with this year’s original artwork by 19-year-old Casey Ford. To expand the patient gallery we ...
By Robin Robinson • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Driving Patient Engagement
A cultural shift throughout pharma is putting patients squarely in the middle of strategic decision-making. Pharmaceutical companies should take a cue from patient advocacy groups to drive patient engagement, and even partner with those advocacy organizations to create better patient experiences ...
By Taren Grom • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient Stories Can Bridge the Gap Between Pharma and Patients
Patients are sharing their stories in an effort to educate other stakeholders, and the pharma industry is using that knowledge sharing to improve on messaging and patient interaction. Patient stories are being used to illustrate organizations’ brand, services, and successes. Hospitals are using t...
By PharmaVoice Team • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient-Enhanced Drug Discovery and Development
Patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation. In other industries, it would seem odd not to get input from the end user of a product throughout the development stages. But it seems that pharmaceutical companies — some ...
By Taren Grom • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Bringing the Patient Voice into Clinical Trials
In an effort to put patients at the center, pharmaceutical companies are starting to gather input from patients earlier in the clinical trial process. Amid growing recognition that patients need to be part of the decision-making process in order to increase the effectiveness of the study, the pha...
By PharmaVoice Team • March 1, 2020
Previous
